Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

A challenging public health policy landscape under health secretary Robert F. Kennedy has vaccine makers rethinking developing for the U.S. market.

Platform-enabled vaccine design unlocks safer, more effective solutions with outer-membrane vesicles (OMVs) emerging as next-generation technology.

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior administration and this administration.” ...